Fundz

Harrow Acquires Santen’S Branded Ophthalmic Portfolio

PUBLIC · HROWJul 18, 2023

Acquiring Company

Harrow

Acquired Company

Portfolio

NashvilleBiotechnologyHealthcareHealth CarePharmaceutical

Description

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of agreements with affiliates of Santen Pharmaceutical Co., Ltd. (“Santen”) under which Harrow will acquire certain U.S. and Canadian commercial rights for the following branded products from Santen:

Who to call at Harrow, and when

When Harrow changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Harrow raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harrow, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harrow. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harrow

Location

Nashville, Tennessee, United States

About

Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications. By closely listening to the needs of providers and patients, the company delivers high-quality products and services. Harrow’s commitment to excellence has made it one of the fastest-growing ophthalmic pharmaceutical companies in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harrow makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Greg
Likely contact at this company
••••••••@••••••••

See Greg's verified email →

Arthur
Senior decision-maker at this company
••••••••@••••••••

See Arthur's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Harrow's next move

Learn about Strategic plan

Frequently asked

Who acquired Portfolio?

Portfolio was acquired by Harrow, based in Nashville. The deal was reported on July 18, 2023. Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications. Harrow is publicly traded (HROW) and operates in Biotechnology.

When did Harrow acquire Portfolio?

Harrow's acquisition of Portfolio was reported on July 18, 2023. Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of agreements with affiliates of Santen Pharmaceutical Co., Ltd. (“Santen”) under which Harrow will acquire certain U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Portfolio do?

Pénzügyi és gazdasági online hírportál. Mikro- és makrogazdasági hírek, elemzések, életrevaló fórumok a szakembereket foglalkoztató kérdésekről. Pénzügyi konferenciák, iparági fórumok, befektetői klubok, Trader tanfolyamok. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.